Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer's disease treatment

Conventional transnasal brain-targeted drug delivery strategies are limited by nasal cilia clearance and the nasal mucosal barrier. To address this challenge, we designed dissolving microneedles combined with nanocarriers for enhanced nose-to-brain drug delivery. To facilitate transnasal administrat...

Ausführliche Beschreibung